XML 28 R22.htm IDEA: XBRL DOCUMENT v3.19.2
Commitments, Contingencies and Other Items
6 Months Ended
Jun. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments, Contingencies and Other Items COMMITMENTS, CONTINGENCIES AND OTHER ITEMS
There are no material changes from the commitments, contingencies and other items previously disclosed in the Company’s Form 10-K for the year ended December 31, 2018, other than disclosures associated with the adoption of FASB ASC Topic Leases as outlined below. See “Note 2. Significant Accounting Policies” for additional information related to the adoption of FASB ASC Topic Leases.
Leases
The Company’s operating leases primarily relate to office space for its global underwriting platforms, principally in Bermuda, Australia, Ireland, Singapore, Switzerland, the U.K. and the U.S. These leases expire at various dates through 2027 with a weighted average lease term of 1.9 years. Included in other assets and other liabilities at June 30, 2019 is a right-to-use asset of $19.1 million and a lease liability of $19.1 million, respectively, associated with the Company’s operating leases and reflected as a result of the Company’s adoption of FASB ASC Topic Leases (December 31, 2018 - $Nil and $Nil, respectively). For the three and six months ended June 30, 2019, the Company recorded an operating lease expense of $2.5 million and $4.2 million, respectively, included in other income (loss) (2018 - $Nil and $Nil, respectively).
The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at June 30, 2019 is a right-to-use asset of $20.2 million and a lease liability of $25.5 million, respectively, associated with the Company’s finance leases and reflected as a result of the Company’s adoption of FASB ASC Topic Leases (December 31, 2018 - $20.6 million and $25.6 million, respectively). For the three and six months ended June 30, 2019, the Company recorded interest expense of $0.6 million and $1.3 million, respectively, associated with its finance leases (2018 - $0.7 million and $1.3 million, respectively) and amortization of its finance leases right-to-use asset of $0.2 million and $0.4 million, respectively, included in other income (loss) (2018 - $0.2 million and $0.4 million, respectively).
Future minimum lease payments under existing operating and finance leases are detailed below, excluding the bargain renewal option on the finance lease related to office space in Bermuda:
 
 
 
 
 
 
 
 
Future minimum lease payments
 
 
 
Operating leases
 
Finance leases
 
 
2019 (remaining)
$
3,935

 
$
1,665

 
 
2020
5,439

 
3,336

 
 
2021
4,962

 
3,336

 
 
2022
4,235

 
3,336

 
 
2023
1,569

 
2,830

 
 
2024
86

 
2,661

 
 
After 2024
211

 
10,129

 
 
Future minimum lease payments under existing leases
$
20,437

 
$
27,293

 
 
 
 
 
 
 

Legal Proceedings
The Company and its subsidiaries are subject to lawsuits and regulatory actions in the normal course of business that do not arise from or directly relate to claims on reinsurance treaties or contracts or direct surplus lines insurance policies. In the Company’s industry, business litigation may involve allegations of underwriting or claims-handling errors or misconduct, disputes relating to the scope of, or compliance with, the terms of delegated underwriting agreements, employment claims, regulatory actions or disputes arising from the Company’s business ventures. The Company’s operating subsidiaries are subject to claims litigation involving, among other things, disputed interpretations of policy coverages. Generally, the Company’s direct surplus lines insurance operations are subject to greater frequency and diversity of claims and claims-related litigation than its reinsurance operations and, in some jurisdictions, may be subject to direct actions by allegedly injured persons or entities seeking damages from policyholders. These lawsuits, involving or arising out of claims on policies issued by the Company’s subsidiaries which are typical to the insurance industry in general and in the normal course of business, are considered in its loss and loss expense reserves. In addition, the Company may from time to time engage in litigation or arbitration related to its claims for payment in respect of ceded reinsurance, including disputes that challenge the Company’s ability to enforce its underwriting intent. Such matters could result, directly or indirectly, in providers of protection not meeting their obligations to the Company or not doing so on a timely basis. The Company may also be subject to other disputes from time to time, relating to operational or other matters distinct from insurance or reinsurance claims. Any litigation or arbitration, or regulatory process contains an element of uncertainty, and the value of an exposure or a gain contingency related to a dispute is difficult to estimate. The Company believes that no individual litigation or arbitration to which it is presently a party is likely to have a material adverse effect on its financial condition, business or operations.